{"product_id":"memorial-sloan-kettering-cancer-center-9th-annual-msk-symposium-on-lymphoma-2025","title":"Memorial Sloan Kettering Cancer Center 9th Annual MSK Symposium on Lymphoma 2025","description":"\u003cdiv\u003e\n\u003ch3\u003eMemorial Sloan Kettering Cancer Center 9th Annual MSK Symposium on Lymphoma 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 37 videos + 30 pdfs, size: 6.71 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003eDate \u0026amp; Location: Friday, April 25, 2025, 8:00 AM – Saturday, April 26, 2025, 12:55 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eSpecialties\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Anatomic Pathology, Bone Marrow Transplant, Cellular Therapeutics, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Molecular Pathology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThis annual symposium provides a comprehensive overview of the latest advancements in the evolving field of lymphoma. Renowned national and international experts present cutting-edge discoveries in lymphoma biology, state-of-the-art diagnostic techniques, and innovative treatment strategies. The program highlights the clinical management of common lymphoma subtypes while also examining groundbreaking drug developments that are redefining patient care. Attendees will gain valuable insights into the latest findings in lymphoma biology and pathology, exploring how these breakthroughs are being translated into practical, impactful solutions for clinical practice.\u003cbr\u003e\u003cbr\u003eThe target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the choice of attending either in-person or virtually.\u003cbr\u003e\u003cbr\u003eWe look forward to welcoming colleagues and esteemed faculty from around the world to exchange insights and advance the future of lymphoma care.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this symposium, attendees will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe recent advances in lymphoma classification\u003c\/li\u003e\n\u003cli\u003eDiscuss first line treatment options in most frequent lymphoma entities\u003c\/li\u003e\n\u003cli\u003eDescribe new agents mode of actions, efficacy, side effects\u003c\/li\u003e\n\u003cli\u003eDiscuss options and recommendations for patients in the relapse refractory setting\u003c\/li\u003e\n\u003cli\u003eProvide adequate information to help shared decision with patients regarding their treatment\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdvances in Biology.mp4\u003cbr\u003eAdvances in Biology.pdf\u003cbr\u003eAdvancing Therapeutic Options in the Relapse Setting.mp4\u003cbr\u003eAdvancing Therapeutic Options in the Relapse Setting.pdf\u003cbr\u003eB-Cell Dynamics in the Germinal Center.mp4\u003cbr\u003eB-Cell Dynamics in the Germinal Center.pdf\u003cbr\u003eBiology of Hodgkin Lymphoma.mp4\u003cbr\u003eBiology of Hodgkin Lymphoma.pdf\u003cbr\u003eCAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.mp4\u003cbr\u003eCAR T-Cell Therapy for B Cell Lymphoma- Approach to Management and Care in the Outpatient Setting.pdf\u003cbr\u003eCellular Therapies for Treating Mantle Cell Lymphoma.mp4\u003cbr\u003eCellular Therapies for Treating Mantle Cell Lymphoma.pdf\u003cbr\u003eCurrent Dilemma in the First Line Therapy Setting.mp4\u003cbr\u003eCurrent Dilemma in the First Line Therapy Setting.pdf\u003cbr\u003eEpidemiology and Outcomes of Lymphoma.mp4\u003cbr\u003eEpidemiology and Outcomes of Lymphoma.pdf\u003cbr\u003eGerminal Center Biology.pdf\u003cbr\u003eHistologic Transformation of Follicular Lymphoma.mp4\u003cbr\u003eHistologic Transformation of Follicular Lymphoma.pdf\u003cbr\u003eLessons and Challenges.mp4\u003cbr\u003eLessons and Challenges.pdf\u003cbr\u003eLymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.mp4\u003cbr\u003eLymphoma Survivorship- Optimizing Quality of Life and Monitoring Long Term Side Effects of Treatment.pdf\u003cbr\u003eLymphoma2025_Brochure.pdf\u003cbr\u003eManagement of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.mp4\u003cbr\u003eManagement of Fertility in Patients with Hodgkin’s and Non-Hodgkin Lymphoma.pdf\u003cbr\u003eManagement of Older Patients.mp4\u003cbr\u003eManagement of Older Patients.pdf\u003cbr\u003eMantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.mp4\u003cbr\u003eMantle Cell Lymphoma in Ambulatory Setting- Focus on Supportive Care and Adverse Event Management.pdf\u003cbr\u003eNew Antibodies Engaging Immune Cells.mp4\u003cbr\u003eNew Antibodies Engaging Immune Cells.pdf\u003cbr\u003eNew Drugs on the Horizon for Follicular Lymphoma.mp4\u003cbr\u003eNew Drugs on the Horizon for Follicular Lymphoma.pdf\u003cbr\u003eNotch and Marginal Zone Biology.mp4\u003cbr\u003eNotch and Marginal Zone Biology.pdf\u003cbr\u003eOptimizing First Line Therapy.mp4\u003cbr\u003eOptimizing First Line Therapy.pdf\u003cbr\u003eOptimizing Patient Selection in 2025.mp4\u003cbr\u003eOptimizing Patient Selection in 2025.pdf\u003cbr\u003eOptions After First Line Treatment Failure.mp4\u003cbr\u003eOptions After First Line Treatment Failure.pdf\u003cbr\u003ePanel Discussion- Advances in Therapeutic Strategies for Mantle Cell Lymphoma.mp4\u003cbr\u003ePanel Discussion- Aggressive B-Cell Lymphoma \u0026amp; Car T-Cell Therapies in Large B-Cell Lymphoma.mp4\u003cbr\u003ePanel Discussion- Aggressive B-Cell Lymphoma- Addressing Remaining Gaps on the Path to a Definitive Cure.mp4\u003cbr\u003ePanel Discussion- Current Challenges in the Management of Patients with Follicular Lymphoma.mp4\u003cbr\u003ePanel Discussion- Empowering APPs and Nurses.mp4\u003cbr\u003ePanel Discussion- Hodgkin Lymphoma.mp4\u003cbr\u003ePanel Discussion- Improving Outcomes of Patients with T-Cell Lymphoma.mp4\u003cbr\u003ePanel Discussion- The Dark Side of B-Cells.mp4\u003cbr\u003eProgress in Large B-Cell Lymphoma Management.mp4\u003cbr\u003eProgress in Large B-Cell Lymphoma Management.pdf\u003cbr\u003eRadiation Therapy and CAR T.mp4\u003cbr\u003eRecent Insights Into Mantle Cell Lymphoma Biology.mp4\u003cbr\u003eRecent Insights Into Mantle Cell Lymphoma Biology.pdf\u003cbr\u003eResearch Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.mp4\u003cbr\u003eResearch Spotlight- Updates of Active Hodgkin’s Lymphoma Protocols at Memorial Sloan Kettering.pdf\u003cbr\u003eSingle Cell Analysis of B-Cell Lymphoma.mp4\u003cbr\u003eSingle Cell Analysis of B-Cell Lymphoma.pdf\u003cbr\u003eThe Evolving Standard of Care in First Line.mp4\u003cbr\u003eThe Evolving Standard of Care in First Line.pdf\u003cbr\u003eTreatment Initiation Versus Active Surveillance.mp4\u003cbr\u003eTreatment Initiation Versus Active Surveillance.pdf\u003cbr\u003eUpdate on Burkitt Lymphoma.mp4\u003cbr\u003eUpdate on Burkitt Lymphoma.pdf\u003cbr\u003eUpdate on Primary Mediastinal B-Cell Lymphoma.mp4\u003cbr\u003eUpdate on Primary Mediastinal B-Cell Lymphoma.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954503323746,"sku":"MED-AMB04813","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Memorial-Sloan-Kettering-Cancer-Center-9th-Annual-MSK-Symposium-on-Lymphoma-2025-3.jpg?v=1779378293","url":"https:\/\/meducourse.com\/products\/memorial-sloan-kettering-cancer-center-9th-annual-msk-symposium-on-lymphoma-2025","provider":"Meducourse","version":"1.0","type":"link"}